Literature DB >> 24451150

Implementation of EUnetHTA core Model® in Lombardia: the VTS framework.

Giovanni Radaelli1, Emanuele Lettieri1, Cristina Masella1, Luca Merlino2, Alberto Strada2, Michele Tringali2.   

Abstract

OBJECTIVES: This study describes the health technology assessment (HTA) framework introduced by Regione Lombardia to regulate the introduction of new technologies. The study outlines the process and dimensions adopted to prioritize, assess and appraise the requests of new technologies.
METHODS: The HTA framework incorporates and adapts elements from the EUnetHTA Core Model and the EVIDEM framework. It includes dimensions, topics, and issues provided by EUnetHTA Core Model to collect data and process the assessment. Decision making is instead supported by the criteria and Multi-Criteria Decision Analysis technique from the EVIDEM consortium.
RESULTS: The HTA framework moves along three process stages: (i) prioritization of requests, (ii) assessment of prioritized technology, (iii) appraisal of technology in support of decision making. Requests received by Regione Lombardia are first prioritized according to their relevance along eight dimensions (e.g., costs, efficiency and efficacy, organizational impact, safety). Evidence about the impacts of the prioritized technologies is then collected following the issues and topics provided by EUnetHTA Core Model. Finally, the Multi-Criteria Decision Analysis technique is used to appraise the novel technology and support Regione Lombardia decision making.
CONCLUSIONS: The VTS (Valutazione delle Tecnologie Sanitarie) framework has been successfully implemented at the end of 2011. From its inception, twenty-six technologies have been processed.

Entities:  

Mesh:

Year:  2014        PMID: 24451150     DOI: 10.1017/S0266462313000639

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  31 in total

1.  Could or Should We Use MCDA in the French HTA Process?

Authors:  Salah Ghabri; Jean-Michel Josselin; Benoît Le Maux
Journal:  Pharmacoeconomics       Date:  2019-12       Impact factor: 4.981

Review 2.  How to Value Orphan Drugs? A Review of European Value Assessment Frameworks.

Authors:  Alessandra Blonda; Yvonne Denier; Isabelle Huys; Steven Simoens
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

3.  Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study.

Authors:  Philip Wahlster; Mireille Goetghebeur; Sandra Schaller; Christine Kriza; Peter Kolominsky-Rabas
Journal:  Health Res Policy Syst       Date:  2015-04-28

4.  Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework.

Authors:  Janine van Til; Catharina Groothuis-Oudshoorn; Marijke Lieferink; James Dolan; Mireille Goetghebeur
Journal:  Cost Eff Resour Alloc       Date:  2014-11-18

5.  A Health Technology Assessment: laparoscopy versus colpoceliotomy.

Authors:  A Damonti; L Ferrario; P Morelli; M Mussi; C Patregnani; E Garagiola; E Foglia; R Pagani; R Carminati; E Porazzi
Journal:  J Prev Med Hyg       Date:  2015

6.  A comparative analysis of a disposable and a reusable pedicle screw instrument kit for lumbar arthrodesis: integrating HTA and MCDA.

Authors:  Claudia Ottardi; Alessio Damonti; Emanuele Porazzi; Emanuela Foglia; Lucrezia Ferrario; Tomaso Villa; Enrico Aimar; Marco Brayda-Bruno; Fabio Galbusera
Journal:  Health Econ Rev       Date:  2017-05-03

7.  Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.

Authors:  Monika Wagner; Hanane Khoury; Liga Bennetts; Patrizia Berto; Jenifer Ehreth; Xavier Badia; Mireille Goetghebeur
Journal:  BMC Cancer       Date:  2017-04-17       Impact factor: 4.430

8.  Improving Hospital Based Medical Procurement Decisions with Health Technology Assessment and Multi-Criteria Decision Analysis.

Authors:  Chai Yang; Yanjun Wang; Xiaoxuan Hu; Yujun Chen; Liting Qian; Fuchang Li; Wei Gu; Qiang Liu; Di Wang; Xiaoqing Chai
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

9.  Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation.

Authors:  Monika Wagner; Hanane Khoury; Jacob Willet; Donna Rindress; Mireille Goetghebeur
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

10.  Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.

Authors:  Aris Angelis; Panos Kanavos
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.